Industry Research Reports

Home > Reports > Chemical & Material > Global Shingles Vaccine Market Research Report 2026

Global Shingles Vaccine Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-04-27

Pages: 122 Pages

Report ld: 6639186

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Shingles Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Shingles Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Shingles Vaccine. The Shingles Vaccine market size, estimates, and forecasts are provided in terms of output/shipments (K Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Shingles Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Shingles Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Merck
GlaxoSmithKline

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Zostavax
Shingrix

Segment by Application

Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Shingles Vaccine manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Shingles Vaccine production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Shingles Vaccine consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Shingles Vaccine Market Overview

1.1 Product Definition

1.2 Shingles Vaccine by Type

1.2.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Zostavax

1.2.3 Shingrix

1.3 Shingles Vaccine by Application

1.3.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Under 50 Years Old

1.3.3 50-60 Years Old

1.3.4 60-70 Years Old

1.3.5 Above 70 Years Old

1.4 Global Market Growth Prospects

1.4.1 Global Shingles Vaccine Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Shingles Vaccine Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Shingles Vaccine Production Estimates and Forecasts (2021–2032)

1.4.4 Global Shingles Vaccine Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Shingles Vaccine Production Market Share by Manufacturers (2021–2026)

2.2 Global Shingles Vaccine Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Shingles Vaccine, Industry Ranking, 2024 vs 2025

2.4 Global Shingles Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Shingles Vaccine Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Shingles Vaccine, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Shingles Vaccine, Product Offerings and Applications

2.8 Global Key Manufacturers of Shingles Vaccine, Date of Entry into the Industry

2.9 Shingles Vaccine Market Competitive Situation and Trends

2.9.1 Shingles Vaccine Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Shingles Vaccine Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Shingles Vaccine Production by Region

3.1 Global Shingles Vaccine Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Shingles Vaccine Production Value by Region (2021–2032)

3.2.1 Global Shingles Vaccine Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Shingles Vaccine by Region (2027–2032)

3.3 Global Shingles Vaccine Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Shingles Vaccine Production Volume by Region (2021–2032)

3.4.1 Global Shingles Vaccine Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Shingles Vaccine by Region (2027–2032)

3.5 Global Shingles Vaccine Market Price Analysis by Region (2021–2032)

3.6 Global Shingles Vaccine Production, Value, and Year-over-Year Growth

3.6.1 North America Shingles Vaccine Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Shingles Vaccine Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Shingles Vaccine Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Shingles Vaccine Production Value Estimates and Forecasts (2021–2032)

4 Shingles Vaccine Consumption by Region

4.1 Global Shingles Vaccine Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Shingles Vaccine Consumption by Region (2021–2032)

4.2.1 Global Shingles Vaccine Consumption by Region (2021–2026)

4.2.2 Global Shingles Vaccine Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Shingles Vaccine Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Shingles Vaccine Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Shingles Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Shingles Vaccine Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Shingles Vaccine Production by Type (2021–2032)

5.1.1 Global Shingles Vaccine Production by Type (2021–2026)

5.1.2 Global Shingles Vaccine Production by Type (2027–2032)

5.1.3 Global Shingles Vaccine Production Market Share by Type (2021–2032)

5.2 Global Shingles Vaccine Production Value by Type (2021–2032)

5.2.1 Global Shingles Vaccine Production Value by Type (2021–2026)

5.2.2 Global Shingles Vaccine Production Value by Type (2027–2032)

5.2.3 Global Shingles Vaccine Production Value Market Share by Type (2021–2032)

5.3 Global Shingles Vaccine Price by Type (2021–2032)

6 Segment by Application

6.1 Global Shingles Vaccine Production by Application (2021–2032)

6.1.1 Global Shingles Vaccine Production by Application (2021–2026)

6.1.2 Global Shingles Vaccine Production by Application (2027–2032)

6.1.3 Global Shingles Vaccine Production Market Share by Application (2021–2032)

6.2 Global Shingles Vaccine Production Value by Application (2021–2032)

6.2.1 Global Shingles Vaccine Production Value by Application (2021–2026)

6.2.2 Global Shingles Vaccine Production Value by Application (2027–2032)

6.2.3 Global Shingles Vaccine Production Value Market Share by Application (2021–2032)

6.3 Global Shingles Vaccine Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Merck

7.1.1 Merck Shingles Vaccine Company Information

7.1.2 Merck Shingles Vaccine Product Portfolio

7.1.3 Merck Shingles Vaccine Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Merck Main Business and Markets Served

7.1.5 Merck Recent Developments/Updates

7.2 GlaxoSmithKline

7.2.1 GlaxoSmithKline Shingles Vaccine Company Information

7.2.2 GlaxoSmithKline Shingles Vaccine Product Portfolio

7.2.3 GlaxoSmithKline Shingles Vaccine Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 GlaxoSmithKline Main Business and Markets Served

7.2.5 GlaxoSmithKline Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Shingles Vaccine Industry Chain Analysis

8.2 Shingles Vaccine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Shingles Vaccine Production Modes and Processes

8.4 Shingles Vaccine Sales and Marketing

8.4.1 Shingles Vaccine Sales Channels

8.4.2 Shingles Vaccine Distributors

8.5 Shingles Vaccine Customer Analysis

9 Shingles Vaccine Market Dynamics

9.1 Shingles Vaccine Industry Trends

9.2 Shingles Vaccine Market Drivers

9.3 Shingles Vaccine Market Challenges

9.4 Shingles Vaccine Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Shingles Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Shingles Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Shingles Vaccine Production Capacity (K Doses) by Manufacturers in 2025

Table 4. Global Shingles Vaccine Production by Manufacturers (K Doses), 2021–2026

Table 5. Global Shingles Vaccine Production Market Share by Manufacturers (2021–2026)

Table 6. Global Shingles Vaccine Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Shingles Vaccine Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Shingles Vaccine, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Shingles Vaccine Production Value, 2025

Table 10. Global Market Shingles Vaccine Average Price by Manufacturers (USD/Dose), 2021–2026

Table 11. Global Key Manufacturers of Shingles Vaccine, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Shingles Vaccine, Product Offerings and Applications

Table 13. Global Key Manufacturers of Shingles Vaccine, Date of Entry into the Industry

Table 14. Global Shingles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Shingles Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Shingles Vaccine Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Shingles Vaccine Production Value Market Share by Region (2021–2026)

Table 19. Global Shingles Vaccine Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Shingles Vaccine Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Shingles Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Doses)

Table 22. Global Shingles Vaccine Production (K Doses) by Region (2021–2026)

Table 23. Global Shingles Vaccine Production Market Share by Region (2021–2026)

Table 24. Global Shingles Vaccine Production (K Doses) Forecast by Region (2027–2032)

Table 25. Global Shingles Vaccine Production Market Share Forecast by Region (2027–2032)

Table 26. Global Shingles Vaccine Market Average Price (USD/Dose) by Region (2021–2026)

Table 27. Global Shingles Vaccine Market Average Price (USD/Dose) by Region (2027–2032)

Table 28. Global Shingles Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Doses)

Table 29. Global Shingles Vaccine Consumption by Region (K Doses), 2021–2026

Table 30. Global Shingles Vaccine Consumption Market Share by Region (2021–2026)

Table 31. Global Shingles Vaccine Forecasted Consumption by Region (K Doses), 2027–2032

Table 32. Global Shingles Vaccine Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Doses)

Table 34. North America Shingles Vaccine Consumption by Country (K Doses), 2021–2026

Table 35. North America Shingles Vaccine Consumption by Country (K Doses), 2027–2032

Table 36. Europe Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Doses)

Table 37. Europe Shingles Vaccine Consumption by Country (K Doses), 2021–2026

Table 38. Europe Shingles Vaccine Consumption by Country (K Doses), 2027–2032

Table 39. Asia Pacific Shingles Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Doses)

Table 40. Asia Pacific Shingles Vaccine Consumption by Region (K Doses), 2021–2026

Table 41. Asia Pacific Shingles Vaccine Consumption by Region (K Doses), 2027–2032

Table 42. Latin America, Middle East & Africa Shingles Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Doses)

Table 43. Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (K Doses), 2021–2026

Table 44. Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (K Doses), 2027–2032

Table 45. Global Shingles Vaccine Production (K Doses) by Type (2021–2026)

Table 46. Global Shingles Vaccine Production (K Doses) by Type (2027–2032)

Table 47. Global Shingles Vaccine Production Market Share by Type (2021–2026)

Table 48. Global Shingles Vaccine Production Market Share by Type (2027–2032)

Table 49. Global Shingles Vaccine Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Shingles Vaccine Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Shingles Vaccine Production Value Market Share by Type (2021–2026)

Table 52. Global Shingles Vaccine Production Value Market Share by Type (2027–2032)

Table 53. Global Shingles Vaccine Price (USD/Dose) by Type (2021–2026)

Table 54. Global Shingles Vaccine Price (USD/Dose) by Type (2027–2032)

Table 55. Global Shingles Vaccine Production (K Doses) by Application (2021–2026)

Table 56. Global Shingles Vaccine Production (K Doses) by Application (2027–2032)

Table 57. Global Shingles Vaccine Production Market Share by Application (2021–2026)

Table 58. Global Shingles Vaccine Production Market Share by Application (2027–2032)

Table 59. Global Shingles Vaccine Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Shingles Vaccine Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Shingles Vaccine Production Value Market Share by Application (2021–2026)

Table 62. Global Shingles Vaccine Production Value Market Share by Application (2027–2032)

Table 63. Global Shingles Vaccine Price (USD/Dose) by Application (2021–2026)

Table 64. Global Shingles Vaccine Price (USD/Dose) by Application (2027–2032)

Table 65. Merck Shingles Vaccine Company Information

Table 66. Merck Shingles Vaccine Specification and Application

Table 67. Merck Shingles Vaccine Production (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021–2026)

Table 68. Merck Main Business and Markets Served

Table 69. Merck Recent Developments/Updates

Table 70. GlaxoSmithKline Shingles Vaccine Company Information

Table 71. GlaxoSmithKline Shingles Vaccine Specification and Application

Table 72. GlaxoSmithKline Shingles Vaccine Production (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021–2026)

Table 73. GlaxoSmithKline Main Business and Markets Served

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Shingles Vaccine Distributors List

Table 78. Shingles Vaccine Customers List

Table 79. Shingles Vaccine Market Trends

Table 80. Shingles Vaccine Market Drivers

Table 81. Shingles Vaccine Market Challenges

Table 82. Shingles Vaccine Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Product Picture of Shingles Vaccine

Figure 2. Global Shingles Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Shingles Vaccine Market Share by Type: 2025 vs 2032

Figure 4. Zostavax Product Picture

Figure 5. Shingrix Product Picture

Figure 6. Global Shingles Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Shingles Vaccine Market Share by Application: 2025 vs 2032

Figure 8. Under 50 Years Old

Figure 9. 50-60 Years Old

Figure 10. 60-70 Years Old

Figure 11. Above 70 Years Old

Figure 12. Global Shingles Vaccine Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Shingles Vaccine Production Value (US$ Million), 2021–2032

Figure 14. Global Shingles Vaccine Production Capacity (K Doses), 2021–2032

Figure 15. Global Shingles Vaccine Production (K Doses), 2021–2032

Figure 16. Global Shingles Vaccine Average Price (USD/Dose), 2021–2032

Figure 17. Shingles Vaccine Report Years Considered

Figure 18. Shingles Vaccine Production Share by Manufacturers in 2025

Figure 19. Global Shingles Vaccine Production Value Share by Manufacturers (2025)

Figure 20. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Top 5 and Top 10 Global Players: Market Share by Shingles Vaccine Revenue in 2025

Figure 22. Global Shingles Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 23. Global Shingles Vaccine Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 24. Global Shingles Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Doses)

Figure 25. Global Shingles Vaccine Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 26. North America Shingles Vaccine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Europe Shingles Vaccine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. China Shingles Vaccine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Japan Shingles Vaccine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 30. Global Shingles Vaccine Consumption by Region: 2021 vs 2025 vs 2032 (K Doses)

Figure 31. Global Shingles Vaccine Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 32. North America Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 33. North America Shingles Vaccine Consumption Market Share by Country (2021–2032)

Figure 34. U.S. Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 35. Canada Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 36. Europe Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 37. Europe Shingles Vaccine Consumption Market Share by Country (2021–2032)

Figure 38. Germany Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 39. France Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 40. U.K. Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 41. Italy Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 42. Russia Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 43. Asia Pacific Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 44. Asia Pacific Shingles Vaccine Consumption Market Share by Region (2021–2032)

Figure 45. China Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 46. Japan Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 47. South Korea Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 48. China Taiwan Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 49. Southeast Asia Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 50. India Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 51. Latin America, Middle East & Africa Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 52. Latin America, Middle East & Africa Shingles Vaccine Consumption Market Share by Country (2021–2032)

Figure 53. Mexico Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 54. Brazil Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 55. Turkey Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 56. GCC Countries Shingles Vaccine Consumption and Growth Rate (K Doses), 2021–2032

Figure 57. Global Production Market Share of Shingles Vaccine by Type (2021–2032)

Figure 58. Global Production Value Market Share of Shingles Vaccine by Type (2021–2032)

Figure 59. Global Shingles Vaccine Price (USD/Dose) by Type (2021–2032)

Figure 60. Global Production Market Share of Shingles Vaccine by Application (2021–2032)

Figure 61. Global Production Value Market Share of Shingles Vaccine by Application (2021–2032)

Figure 62. Global Shingles Vaccine Price (USD/Dose) by Application (2021–2032)

Figure 63. Shingles Vaccine Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Shingles Vaccine market? zhanKai

The top companies in the global Shingles Vaccine market are Merck、GlaxoSmithKline.

Related Reports

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 118
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 129
USD 4900.00
(Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 65
USD 4250.00
(Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 81
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-19
Pages: 72
USD 4900.00
(Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 84
USD 2900.00
(Single User License)

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 118
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 129
USD 4900.00 (Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 65
USD 4250.00 (Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 81
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-19
Pages: 72
USD 4900.00 (Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 84
USD 2900.00 (Single User License)